SUVEN LIFE SCIENCES LTD. - 530239 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
With reference to above subject, please find enclosed News Release of our company titled 'Suven Life Sciences Limited Announces Randomization of First Patient in Phase-3 Global Clinical Trial of Masupirdine (SUVN-502) for the Treatment of Agitation in Patients with Dementia of the Alzheimer''s Type' This is for your information and record. SUVEN LIFE SCIENCES LTD. - 530239 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Pursuant to Regulation 47 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 as amended, please find enclosed the copies of the newspaper advertisement regarding Un-audited Financial Results of the Company for quarter ended 30th September, 2022. The advertisements are as appeared on 11th November, 2022 in Business Standard and Andhra Prabha (Telugu). SUVEN LIFE SCIENCES LTD. - 530239 - Statement Of Deviation(S) Or Variation(S) For Quarter Ended 30Th September, 2022 Under Regulation 32 Of SEBI (LODR) Regulations, 2015
With reference to the above subject, please find enclosed statement confirming that there were no deviation(s) or variation(s) in the use of proceeds, from the objects for which funds were raised through the preferential issue made by the Company, for the quarter ended 30th September, 2022. SUVEN LIFE SCIENCES LTD. - 530239 - Outcome Of The Board Meeting
With reference to the above subject, pursuant to Regulation 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the Board of Directors of the company at its meeting held today i.e. November 10, 2022, has taken on record and approved Un-audited Standalone and Consolidated Financial Results of the Company under Ind AS along with review reports of the Statutory Auditors for the quarter and half-year ended September 30, 2022. SUVEN LIFE SCIENCES LTD. - 530239 - Board Meeting Intimation for Intimation Of Board Meeting Of The Company To Be Held On Thursday, November 10, 2022 - Reg.,
SUVEN LIFE SCIENCES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 10/11/2022 ,inter alia, to consider and approve the Un-audited Financial Results (Standalone and Consolidated) of the Company under Ind AS for the quarter and half-year ended September 30, 2022 and related matters. SUVEN LIFE SCIENCES LTD. - 530239 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Please note that the Company has issued an advertisement under Regulation 84(1) of the SEBI ICDR Regulations, which includes, inter alia, details of the date of completion of despatch of the abridged letter of offer and application form, details in relation to centres where shareholders or persons entitled to receive rights entitlement may obtain duplicate copies of applications forms and details in relation to applications on plain paper by shareholders (Advertisement). SUVEN LIFE SCIENCES LTD. - 530239 - Statement Of Investor Complaints For The Quarter Ended September 2022
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0880 Name of the Signatory :- SHRENIK SONIDesignation :- Company Secretary and Compliance Officer SUVEN LIFE SCIENCES LTD. - 530239 - Board Meeting Outcome for Outcome Of The Meeting Of The Rights Issue Committee Of Board Of Directors Of Suven Life Sciences Limited Held Today I.E. Tuesday, October 18, 2022.
In furtherance to our intimation dated October 12, 2022 informing approval of the terms and conditions of the Rights Issue, we wish to inform that Rights Issue Committee of the Board of Directors of the Company, at their meeting held today i.e. Tuesday, October 18, 2022, inter-alia considered and approved the following: a) Issue period: 1. Issue Opening Date: Monday, October 31, 2022 2. Issue Closing Date: Thursday, November 10, 2022. b) the Letter of Offer (LOF) to be filed with Securities and Exchange Board of India, BSE Limited and National Stock Exchange of India Limited.
Suven Life Science rights issue: Record date announced. 5 things you should know
Suven Life Sciences' record date for rights issue has been fixed on 18th October 2022 Suven Life Science rights issue: Record date announced. 5 things you should know
Suven Life Sciences' record date for rights issue has been fixed on 18th October 2022